DeepMed Research

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Advance Provision of Medication Abortion

Phase 4

Withdrawn

Conditions: Early Abortion

Interventions: Drug: Mifeprex® (Mifepristone 200 mg)
Drug: Misoprostol 800 mcg
Drug: ella® (ulipristal acetate emergency contraception 30 mg)
Diagnostic Test: AccuHome® Pregnancy OTC Test

First Posted Date: 2019-02-04

Last Posted Date: 2019-05-30

Lead Sponsor: University of California, San Francisco

Registration Number: NCT03829696

Effect of Methamphetamine on Residual Latent HIV Disease Study

Phase 4

Completed

Conditions: HIV-1-infection
Methamphetamine-dependence

Interventions: Drug: Oral Methamphetamine
Other: Placebo oral capsule

First Posted Date: 2019-01-31

Last Posted Date: 2025-04-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 14

Registration Number: NCT03825536

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

The Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk

Conditions: Infertility
Cardiovascular Risk Factor

First Posted Date: 2019-01-31

Last Posted Date: 2023-11-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 865

Registration Number: NCT03825120

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Head Pulse for Ischemic Stroke Detection

Completed

Conditions: Acute Ischemic Stroke

Interventions: Diagnostic Test: Cranial Accelerometry Measurement

First Posted Date: 2019-01-31

Last Posted Date: 2023-04-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 42

Registration Number: NCT03824496

Locations: 🇺🇸
UCSF, San Francisco, California, United States

The Effect of NAC on Lung Function and CT Mucus Score

Phase 4

Terminated

Conditions: Asthma

Interventions: Drug: n-acetylcystine + albuterol
Drug: 0.9% saline + albuterol

First Posted Date: 2019-01-30

Last Posted Date: 2025-03-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 4

Registration Number: NCT03822637

Locations: 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States

Continuous Versus Cyclical OCP Use in PCOS

Phase 4

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Yasmin

First Posted Date: 2019-01-28

Last Posted Date: 2023-01-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT03819140

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Improving BP Control in Diverse Populations Using BP MAP

Not Applicable

Completed

Conditions: Hypertension

Interventions: Other: Self-Guided M.A.P. BP Improvement Program
Other: Full Support M.A.P. BP Improvement Program

First Posted Date: 2019-01-28

Last Posted Date: 2025-03-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1238835

Registration Number: NCT03818659

Locations: 🇺🇸
Public Health: Seattle & King County Downtown Public Health Center, Seattle, Washington, United States
🇺🇸
QueensCare Echo Park Clinic, Los Angeles, California, United States
🇺🇸
Monterey County Health Department Laurel Family Practice, Salinas, California, United States

and more 21 locations

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1

Completed

Conditions: Castration-Resistant Prostate Carcinoma
Stage IVA Prostate Cancer
Stage IVB Prostate Cancer
Prostate Adenocarcinoma
Castration Levels of Testosterone
Metastatic Prostate Carcinoma
Stage IV Prostate Cancer

Interventions: Drug: Lutetium Lu 177-PSMA-617
Biological: Pembrolizumab

First Posted Date: 2019-01-15

Last Posted Date: 2025-02-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 43

Registration Number: NCT03805594

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Developmental Epidemiological Study of Children Born Through Reproductive Technology

Active, not recruiting

Conditions: Infertility Unexplained
Infertility, Male
Infertility Primary
Infertility
Infertility, Female
Infertility Secondary

First Posted Date: 2019-01-10

Last Posted Date: 2024-01-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3700

Registration Number: NCT03799107

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

The PCORnet Blood Pressure Home Monitoring Study

Not Applicable

Completed

Conditions: Hypertension

Interventions: Device: Standard HBPM
Device: Smartphone-linked HBPM and associated app

First Posted Date: 2019-01-08

Last Posted Date: 2022-11-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2238

Registration Number: NCT03796689

Locations: 🇺🇸
University of Florida Health, Gainesville, Florida, United States
🇺🇸
University Medical Center, New Orleans, Louisiana, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy